// App-Quantinova.ai

155 : Effect of covid-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension

Researchers

Presenter

  • Christian Battersby

Principal Investigators

  • Robin Condliffe

  • David G Kiely

  • Charlie Elliot

  • Jennifer Tegan Middleton

  • Junaid Patel

  • Dharshan Neelam-Naganathan

  • Robert Lewis

  • Sarah Binmahfooz

  • Andy J Swift

  • Abdul Hameed

  • Mark Toshner

  • Alexander M K Rothman

  • Roger Thompson

  • Hamza Zafar

  • Ashwin Reddy

  • Athanasios Charalampopoulos

  • Lisa Watson

Medical Centers

  • Royal Papworth Hospital NHS Foundation Trust, Cambridgeshire, United Kingdom

  • Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield

  • Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield

  • The University of Sheffield

  • University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease

  • Department of immunity, infection and cardiovascular disease, University of Sheffield

  • The University of Sheffield

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Pulmonary arterial hypertension

  • Depression

  • Coronavirus disease

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final